If you’ve tried multiple antidepressants without lasting relief, you’re not alone—and you’re not out of options.
Many people living with treatment-resistant depression reach a point where traditional medications stop working as expected. That’s where Spravato for depression, an innovative esketamine-based nasal spray, can make a difference.
This guide explains what Spravato for depression is, how it works, who qualifies for it, and what you can expect during treatment.
What is Spravato (esketamine nasal spray), and how is it different from typical antidepressants?
Spravato for depression is a prescription nasal spray that contains esketamine—a chemical cousin of ketamine, long used in anesthesia and increasingly recognized for its rapid antidepressant effects.
Traditional antidepressants, such as SSRIs or SNRIs, work by gradually increasing levels of serotonin or norepinephrine in the brain. They can take weeks to show improvement. Spravato for depression, however, targets a different system altogether—the glutamate pathway, which plays a key role in mood regulation, neuroplasticity, and stress response.
By stimulating NMDA (N-methyl-D-aspartate) receptors, Spravato for depression helps create new neural connections that may relieve depressive symptoms within hours or days rather than weeks. Many patients describe a sense of “lightness,” emotional clarity, or renewed motivation shortly after starting treatment.
Because it works differently, Spravato can be effective for individuals who haven’t responded to other medications.
Who qualifies for Spravato treatment, and what qualifies as “treatment-resistant depression”?
Spravato for depression is specifically approved for adults diagnosed with treatment-resistant depression (TRD)—meaning they’ve tried at least two traditional antidepressant medications, at adequate doses and durations, without significant improvement.
You may qualify for Spravato for depression if you:
- Have major depressive disorder that hasn’t responded to multiple antidepressants.
- Experience persistent symptoms such as hopelessness, fatigue, or disconnection.
- Are currently under the care of a psychiatrist or mental health provider.
- Are open to supervised, in-clinic treatments administered by a certified Spravato provider.
Spravato for depression is not typically used as a first-line antidepressant or for mild depressive symptoms. Instead, it’s an advanced option designed for individuals who need a new approach after conventional treatments haven’t helped.
Your clinician will conduct a full evaluation to ensure Spravato is safe and appropriate, considering your medical history, current medications, and mental health goals.
What is the treatment protocol for Spravato (frequency of dosing, monitoring, clinic visits)?
Spravato for depression is administered only in certified medical settings under the supervision of trained professionals. This ensures safety, accuracy, and close monitoring during and after each session.
Here’s what a typical course looks like:
- Induction Phase (Weeks 1–4): Two treatments per week.
- Maintenance Phase (Weeks 5–8): One treatment per week.
- Ongoing Maintenance: Once every one to two weeks, as needed.
During each session:
- You’ll self-administer Spravato for depression under your provider’s guidance.
- You’ll remain in the clinic for approximately two hours afterward for observation.
- Your blood pressure, mood, and physical comfort will be closely monitored.
Because Spravato can cause temporary sedation or dizziness, patients must arrange transportation home after each appointment—driving or operating heavy machinery the same day isn’t permitted.
This structured approach allows your psychiatric provider to track your progress, adjust the dosing schedule, and ensure that Spravato for depression continues to support your recovery safely.
What side effects or risks are associated with Spravato, and what should patients know about post-treatment monitoring?
Spravato for depression is generally well tolerated, but like any medication, it can cause side effects—most of which are temporary and occur during or shortly after treatment.
Common side effects include:
- Mild dissociation or a “dreamlike” feeling.
- Dizziness or lightheadedness.
- Increased blood pressure during treatment (usually short-lived).
- Nausea or mild headache.
- Fatigue or sedation.
These effects typically fade within one to two hours. That’s why patients remain at the clinic under observation until they feel fully stable.
Rarely, Spravato may cause stronger dissociative experiences or elevated blood pressure that requires closer monitoring—but providers are trained to respond quickly if this occurs.
After leaving the clinic, most people feel tired or “foggy,” so rest is encouraged for the remainder of the day. Over time, as your body adjusts, side effects often lessen or disappear entirely.
Your clinician will continue checking in to ensure Spravato for depression is helping you progress safely and meaningfully.
A New Approach to Healing
If traditional medications haven’t helped, Spravato for depression may offer a different path forward—one that works on a faster timescale and through new brain pathways. It’s not about replacing your care plan, but expanding it.
Our psychiatry team provides comprehensive evaluations and supervised Spravato treatments, helping patients safely navigate every step of the process.
If you’re ready to explore whether Spravato for depression could be the next step in your healing journey, reach out today. Relief may be closer than you think.